Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q1 2015 · 10-Q
Revenue$0.00$0.00— vs Q1 2014 Net Income-$1.29M-$1.29MN/M vs Q1 2014 EPS Diluted-$0.01-$0.01N/M vs Q1 2014 Operating Income-$562,442N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 13, 2015 · 43 d after period end